Bengaluru: South Asia-based microbiome-focused company Leucine Rich Bio has announced it has received accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL), further validating the company’s laboratory competence and operational reliability.
The NABL accreditation, based on ISO/IEC 17025 standards, confirms that the company’s testing processes meet stringent global benchmarks for technical accuracy and laboratory performance.
Leucine Rich Bio claims to be India’s only microbiome-dedicated organisation to hold both NABL and NABH accreditations, alongside ISO 9001:2015 and ISO 17025 certifications.
While NABL and ISO 17025 affirm technical precision and reliable lab results, NABH accreditation reflects adherence to established clinical protocols and patient safety norms. The ISO 9001:2015 certification signifies robust quality management systems across the organisation.
The company says these accreditations are critical to ensuring diagnostic accuracy and clinical reliability in microbiome testing, underscoring its commitment to high standards in personalised healthcare.
